To learn more about PDT coverage through exclusive industry leader insight into PDT market access, evaluation, and delivery, visit the excellence forum.
To read more about PDT neurodevelopmental treatment options, click here.
To learn more about PDT coverage through exclusive industry leader insight into PDT market access, evaluation, and delivery, visit the excellence forum.
To read more about PDT neurodevelopmental treatment options, click here.
In an interview with First Report Managed Care, Scott Kollins, PhD, chief medical officer of Akili Interactive, shares research findings related to prescription digital therapeutic treatments for ADHD.
In an interview with First Report Managed Care, Scott Kollins, PhD, chief medical officer of Akili Interactive, shares research findings related to prescription digital therapeutic treatments for ADHD.
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Alit Stark-Inbar, PhD, and Alon Ironi, both affiliated with Theranica, share their research into a prescription digital therapeutic that provides remote electrical neuromodulation for migraine prevention and acute treatment.
Alit Stark-Inbar, PhD, and Alon Ironi, both affiliated with Theranica, share their research into a prescription digital therapeutic that provides remote electrical neuromodulation for migraine prevention and acute treatment.
Experts at Asembia's AXS23 Summit discussed the current landscape of prescription digital therapeutics (PDTs), recent data on payer perceptions, and support strategies for future PDT market access.
Experts at Asembia's AXS23 Summit discussed the current landscape of prescription digital therapeutics (PDTs), recent data on payer perceptions, and support strategies for future PDT market access.
In a session at Asembia’s AXS23 Summit, a panel discussed payer trends in rare disease management and offered different perspectives on how the data from a recent report can be leveraged to improve outcomes.
In a session at Asembia’s AXS23 Summit, a panel discussed payer trends in rare disease management and offered different perspectives on how the data from a recent report can be leveraged to improve outcomes.
Whitney Stewart, director of clinical project management, Curebase, discusses the challenges of bringing digital therapeutics (DTx) to market and outlines methods to improve guidance and standards for DTx studies.
Whitney Stewart, director of clinical project management, Curebase, discusses the challenges of bringing digital therapeutics (DTx) to market and outlines methods to improve guidance and standards for DTx studies.
Lisa Palko, PharmD, vice president of medical affairs, Akili Therapeutics, discusses an exploratory analysis which tested a prescription digital therapeutic's efficacy in pediatric patients with attention-deficit/hyperactivity disorder.
Lisa Palko, PharmD, vice president of medical affairs, Akili Therapeutics, discusses an exploratory analysis which tested a prescription digital therapeutic's efficacy in pediatric patients with attention-deficit/hyperactivity disorder.
As part of the TEAR trial, researchers studied the impact of methotrexate monotherapy or combination therapy with hydroxychloroquine plus sulfasalazine or in combination with etanercept on improving high-density lipoprotein (HDL) cholesterol...
As part of the TEAR trial, researchers studied the impact of methotrexate monotherapy or combination therapy with hydroxychloroquine plus sulfasalazine or in combination with etanercept on improving high-density lipoprotein (HDL) cholesterol...
Results of a study on the effect of cochlear implantation (CI) on language development found that bilateral implantation was more advantageous than unilateral implantation in pediatric patients, according to findings reported in the Archives...
Results of a study on the effect of cochlear implantation (CI) on language development found that bilateral implantation was more advantageous than unilateral implantation in pediatric patients, according to findings reported in the Archives...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.